✦ LIBER ✦

Comparison of Bivalirudin Versus Bivalirudin Plus Glycoprotein IIb/IIIa Inhibitor Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitor in Patients With Acute Coronary Syndromes Having Percutaneous Intervention for Narrowed Saphenous Vein Aorto-Coronary Grafts (the ACUITY Trial Investigators)

✍ Scribed by Dinesh Kumar; George Dangas; Roxana Mehran; Ajay Kirtane; Michel Bertrand; Ramin Ebrahimi; Giulio Guagliumi; Somjot Brar; Martin Fahy; Eric Heller; Jeffrey Moses; Gregg Stone

Book ID: 113447547
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 152 KB
Volume: 106
Category: Article
ISSN: 0002-9149
DOI: 10.1016/j.amjcard.2010.06.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

TCT-10: Bivalirudin versus Heparin Plus

TCT-10: Bivalirudin versus Heparin Plus Glycoprotein Inhibitors In Patients With Acute Coronary Syndromes And Prior Coronary Artery Bypass Grafting: Analysis From The Acuity Trial

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 153 KB

Bleeding Risk and Outcomes of Bivalirudi

Bleeding Risk and Outcomes of Bivalirudin Versus Glycoprotein IIb/IIIa Inhibitors With Targeted Low-Dose Unfractionated Heparin in Patients Having Percutaneous Coronary Intervention for Either Stable or Unstable Angina Pectoris

✍ Daniel H. Steinberg; Palak Shah; Tim Kinnaird; Tina L. Pinto Slottow; Probal K. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 137 KB